» Articles » PMID: 39695402

Interictal Burden in Migraine Patients at the Outset of CGRP Monoclonal Antibody Prevention

Overview
Journal J Headache Pain
Publisher Biomed Central
Date 2024 Dec 18
PMID 39695402
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The total burden of migraine includes not only the episodes with headache pain but extends throughout the interictal periods. Interictal symptoms and associated psychological responses may profoundly impact well-being and drive treatment-seeking behavior.

Methods: A cross-sectional online survey was conducted with participants aged ≥ 18 years, 250 with episodic migraine (EM) and 250 with chronic migraine (CM), having ≥ 4 monthly migraine headache days. All were naïve to galcanezumab or began ≤ 6 months before survey completion. The study evaluated factors associated with the Migraine Interictal Burden Scale (MIBS-4), including social determinants of health and well-being. Multiple linear regression, logistic regression, and random forests (RF) were used to explore predictors of MIBS-4.

Results: The majority of participants (90%) were female with a mean (standard deviation) age of 40.6 (± 12.0) years and 18.1 (± 12.7) years since the first migraine episode. Sociodemographically, the EM and CM groups were similar. Common comorbidities were anxiety disorder (45%) and depression (44%). Migraine family history was reported in 59% of participants. MIBS-4 was correlated with a number of diverse variables, including well-being, anxiety sensitivity, income, aura symptoms, and the worst migraine pain in the year before starting galcanezumab. Linear and logistic regression identified years since the first symptom, worst migraine attack pain, premonitory symptoms, and income as significant predictors. RF explained more of the variance than multiple linear regression and introduced additional concepts to the prediction of MIBS, identifying well-being (WHO-5 total score), the WHO-5 item "cheerful and in good spirits," worry about exercise, and fear of missing social obligations as significant predictors. Socioeconomic status and income were also critical explanatory variables for interictal burden (IIB) based on regression modeling and RF. Still, income was the only variable significantly associated with IIB across regression and RF methods.

Conclusions: Interictal burden should be considered in the medical care of people with migraine. This additional burden is holistic, with psychosocial and socioeconomic elements in addition to residual symptoms. It is essential to consider this when assessing the impact of IIB.

Citing Articles

The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region.

Dong L, Dong W, Jin Y, Jiang Y, Li Z, Yu D Pain Ther. 2024; 14(1):297-315.

PMID: 39661241 PMC: 11751287. DOI: 10.1007/s40122-024-00690-7.

References
1.
Steiner T, Stovner L, Jensen R, Uluduz D, Katsarava Z . Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020; 21(1):137. PMC: 7708887. DOI: 10.1186/s10194-020-01208-0. View

2.
Leonardi M, Guastafierro E, Toppo C, DAmico D . Societal and personal impact of migraine. Handb Clin Neurol. 2023; 198:23-29. DOI: 10.1016/B978-0-12-823356-6.00015-9. View

3.
Topp C, Ostergaard S, Sondergaard S, Bech P . The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015; 84(3):167-76. DOI: 10.1159/000376585. View

4.
Silberstein S, Holland S, Freitag F, Dodick D, Argoff C, Ashman E . Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012; 78(17):1337-45. PMC: 3335452. DOI: 10.1212/WNL.0b013e3182535d20. View

5.
Buse D, Loder E, Gorman J, Stewart W, Reed M, Fanning K . Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013; 53(8):1278-99. DOI: 10.1111/head.12150. View